1. Home
  2. IVVD vs ZEO Comparison

IVVD vs ZEO Comparison

Compare IVVD & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • ZEO
  • Stock Information
  • Founded
  • IVVD 2020
  • ZEO 2005
  • Country
  • IVVD United States
  • ZEO United States
  • Employees
  • IVVD N/A
  • ZEO N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • ZEO
  • Sector
  • IVVD Health Care
  • ZEO
  • Exchange
  • IVVD Nasdaq
  • ZEO NYSE
  • Market Cap
  • IVVD 69.0M
  • ZEO 55.5M
  • IPO Year
  • IVVD 2021
  • ZEO N/A
  • Fundamental
  • Price
  • IVVD $0.74
  • ZEO $2.49
  • Analyst Decision
  • IVVD Strong Buy
  • ZEO
  • Analyst Count
  • IVVD 3
  • ZEO 0
  • Target Price
  • IVVD $5.85
  • ZEO N/A
  • AVG Volume (30 Days)
  • IVVD 1.3M
  • ZEO 89.9K
  • Earning Date
  • IVVD 08-13-2025
  • ZEO 08-18-2025
  • Dividend Yield
  • IVVD N/A
  • ZEO N/A
  • EPS Growth
  • IVVD N/A
  • ZEO N/A
  • EPS
  • IVVD N/A
  • ZEO N/A
  • Revenue
  • IVVD $36,688,000.00
  • ZEO $61,885,622.00
  • Revenue This Year
  • IVVD $446.60
  • ZEO N/A
  • Revenue Next Year
  • IVVD $112.63
  • ZEO N/A
  • P/E Ratio
  • IVVD N/A
  • ZEO N/A
  • Revenue Growth
  • IVVD N/A
  • ZEO N/A
  • 52 Week Low
  • IVVD $0.35
  • ZEO $1.05
  • 52 Week High
  • IVVD $2.74
  • ZEO $4.75
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 48.03
  • ZEO 43.01
  • Support Level
  • IVVD $0.70
  • ZEO $2.66
  • Resistance Level
  • IVVD $0.77
  • ZEO $2.80
  • Average True Range (ATR)
  • IVVD 0.05
  • ZEO 0.28
  • MACD
  • IVVD -0.00
  • ZEO -0.09
  • Stochastic Oscillator
  • IVVD 45.94
  • ZEO 1.65

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: